SERA Stock Summary and Trading Ideas (Sera Prognostics - Class A | NASDAQ:SERA)

Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Sera Prognostics - Class A trades on the NASDAQ stock market under the symbol SERA.

As of September 4, 2026, SERA stock price climbed to $2.02 with 10,512 million shares trading.

SERA has a beta of 1.58, meaning it tends to be more sensitive to market movements. SERA has a correlation of 0.06 to the broad based SPY ETF.

SERA has a market cap of $79.69 million. This is considered a Micro Cap stock.

Last quarter Sera Prognostics - Class A reported $30,000 in Revenue and -$.18 earnings per share. This fell short of revenue expectation by $-36,000 and missed earnings estimates by -$.02.

In the last 3 years, SERA traded as high as $12.36 and as low as $1.37.

The top ETF exchange traded funds that SERA belongs to (by Net Assets): VTI, VXF, BUSM, AVSC, DCOR.

SERA has underperformed the market in the last year with a price return of -40.8% while the SPY ETF gained +19.8%. SERA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.0% and -5.6%, respectively, while the SPY returned +2.0% and +0.6%, respectively.

SERA support price is $1.87 and resistance is $2.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SERA shares will trade within this expected range on the day.